These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26735018)

  • 21. Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas.
    Ponnaluri VK; Vavilala DT; Prakash S; Mukherji M
    Biochem Biophys Res Commun; 2013 Aug; 438(1):71-7. PubMed ID: 23872148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DYRK1A Negatively Regulates CDK5-SOX2 Pathway and Self-Renewal of Glioblastoma Stem Cells.
    Chen B; McCuaig-Walton D; Tan S; Montgomery AP; Day BW; Kassiou M; Munoz L; Recasens A
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations.
    Rathmell WK; Hickey MM; Bezman NA; Chmielecki CA; Carraway NC; Simon MC
    Cancer Res; 2004 Dec; 64(23):8595-603. PubMed ID: 15574766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein.
    Groulx I; Lee S
    Mol Cell Biol; 2002 Aug; 22(15):5319-36. PubMed ID: 12101228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The HIF1α/HIF2α-miR210-3p network regulates glioblastoma cell proliferation, dedifferentiation and chemoresistance through EGF under hypoxic conditions.
    Wang P; Yan Q; Liao B; Zhao L; Xiong S; Wang J; Zou D; Pan J; Wu L; Deng Y; Wu N; Gong S
    Cell Death Dis; 2020 Nov; 11(11):992. PubMed ID: 33208727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxylation-Dependent Interaction of Substrates to the Von Hippel-Lindau Tumor Suppressor Protein (VHL).
    Heir P; Ohh M
    Methods Mol Biol; 2016; 1458():87-94. PubMed ID: 27581016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway.
    Lu N; Hui H; Yang H; Zhao K; Chen Y; You QD; Guo QL
    Eur J Pharm Sci; 2013 May; 49(2):220-6. PubMed ID: 23501055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5.
    Elorza A; Soro-Arnáiz I; Meléndez-Rodríguez F; Rodríguez-Vaello V; Marsboom G; de Cárcer G; Acosta-Iborra B; Albacete-Albacete L; Ordóñez A; Serrano-Oviedo L; Giménez-Bachs JM; Vara-Vega A; Salinas A; Sánchez-Prieto R; Martín del Río R; Sánchez-Madrid F; Malumbres M; Landázuri MO; Aragonés J
    Mol Cell; 2012 Dec; 48(5):681-91. PubMed ID: 23103253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RHOBTB3 promotes proteasomal degradation of HIFα through facilitating hydroxylation and suppresses the Warburg effect.
    Zhang CS; Liu Q; Li M; Lin SY; Peng Y; Wu D; Li TY; Fu Q; Jia W; Wang X; Ma T; Zong Y; Cui J; Pu C; Lian G; Guo H; Ye Z; Lin SC
    Cell Res; 2015 Sep; 25(9):1025-42. PubMed ID: 26215701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ASCL1 phosphorylation and ID2 upregulation are roadblocks to glioblastoma stem cell differentiation.
    Azzarelli R; McNally A; Dell'Amico C; Onorati M; Simons B; Philpott A
    Sci Rep; 2022 Feb; 12(1):2341. PubMed ID: 35149717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ubiquitination and regulation of AURKA identifies a hypoxia-independent E3 ligase activity of VHL.
    Hasanov E; Chen G; Chowdhury P; Weldon J; Ding Z; Jonasch E; Sen S; Walker CL; Dere R
    Oncogene; 2017 Jun; 36(24):3450-3463. PubMed ID: 28114281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors.
    Aprelikova O; Chandramouli GV; Wood M; Vasselli JR; Riss J; Maranchie JK; Linehan WM; Barrett JC
    J Cell Biochem; 2004 Jun; 92(3):491-501. PubMed ID: 15156561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of SOCS and VHL Proteins in Neuronal Differentiation and Development.
    Kanno H; Matsumoto S; Yoshizumi T; Nakahara K; Kubo A; Murata H; Shuin T; U HS
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype.
    Heddleston JM; Li Z; McLendon RE; Hjelmeland AB; Rich JN
    Cell Cycle; 2009 Oct; 8(20):3274-84. PubMed ID: 19770585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
    Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
    Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Junction plakoglobin regulates and destabilizes HIF2α to inhibit tumorigenesis of renal cell carcinoma.
    Chen K; Zeng J; Sun Y; Ouyang W; Yu G; Zhou H; Zhang Y; Yao W; Xiao W; Hu J; Xing J; Xiao K; Wu L; Chen Z; Ye Z; Xu H
    Cancer Commun (Lond); 2021 Apr; 41(4):316-332. PubMed ID: 33591636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Oxygen Sensor PHD2 Controls Dendritic Spines and Synapses via Modification of Filamin A.
    Segura I; Lange C; Knevels E; Moskalyuk A; Pulizzi R; Eelen G; Chaze T; Tudor C; Boulegue C; Holt M; Daelemans D; Matondo M; Ghesquière B; Giugliano M; Ruiz de Almodovar C; Dewerchin M; Carmeliet P
    Cell Rep; 2016 Mar; 14(11):2653-67. PubMed ID: 26972007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic HIF1A regulation during human placental development.
    Ietta F; Wu Y; Winter J; Xu J; Wang J; Post M; Caniggia I
    Biol Reprod; 2006 Jul; 75(1):112-21. PubMed ID: 16611863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restricted expression of miR-30c-2-3p and miR-30a-3p in clear cell renal cell carcinomas enhances HIF2α activity.
    Mathew LK; Lee SS; Skuli N; Rao S; Keith B; Nathanson KL; Lal P; Simon MC
    Cancer Discov; 2014 Jan; 4(1):53-60. PubMed ID: 24189146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance.
    Li S; Rodriguez J; Li W; Bullova P; Fell SM; Surova O; Westerlund I; Topcic D; Bergsland M; Stenman A; Muhr J; Nistér M; Holmberg J; Juhlin CC; Larsson C; von Kriegsheim A; Kaelin WG; Schlisio S
    Proc Natl Acad Sci U S A; 2019 Aug; 116(34):16997-17006. PubMed ID: 31375625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.